Abstract:Background: Charcot-Marie-Tooth subtype 2A (CMT2A) is an autosomal dominant single-gene motor sensory neuropathy that is caused by mitofusin 2 (Mfn2) mutation. It is generally believed that CMT2A involves mitochondrial fusion disruption. However, how to ameliorate the loss of mitochondrial membrane fusion in CMT2A remains unclear. Methods: In vivo and in vitro mouse models harboring the Mfn2H165R, Mfn2G176S and Mfn2R364W mutations were constructed. We first examined mitochondrial damage and pathophysiological features of Mfn2 mutations. Then, we started with the proteins Mfn2 and Opa1 to analyze the mechanism of mitochondrial aggregation and fragmentation. Findings: Studies have shown that, in Mfn2R364W, Mfn2G176S, Mfn2H165R/+ mutations, fragmentation of mitochondria is mainly mediated by optic atrophy 1 (Opa1) hydrolytic cleavage rather than loss of Mfn2, as Mfn2 expression is activated by Bax translocation. While in Mfn2 H165R/H165R mutation, Opa1 hydrolytic cleavage and Mfn2 loss induced mitochondrial fragmentation and aggregation. Furthermore, in all mutations, hydrolytic cleavage of Opal is mediated by dissipation of mitochondrial membrane potential (MMP), apoptosis, and consequent uncoupling of oxidative phosphorylation. Interpretation: Mitochondrial aggregation and hydrolytic cleavage of Opa1 are two independent pathways of CMT2A pathogenesis: Opa1-induced mitochondrial fragmentation affects the stability of mitochondrial DNA and causes mitochondrial dysfunction, which ultimately leads to CMT2A; mitochondrial transport defect caused by loss of Mfn2 also contributes to the pathogenesis of CMT2A. Funding Information: This study was financially supported by a grant from the Special Funds for Cultivation and Breeding of New Transgenic Organisms (No. 2016ZX08006003), the Program for JLU Science and Technology Innovative Research Team (2017TD-28).Declaration of Interests: The authors declare no competing interest.Ethics Approval Statement: All animal studies were approved by the Animal Welfare and Research Ethics Committee of Jilin University, and all procedures were conducted in strict accordance with the Guide for the Care and Use of Laboratory Animals. The mice were euthanized at humane end-points or the predetermined end of the experiment. The animal carcasses were treated in a standardized and respectful manner after the experiment.

DHTKD1 Deficiency Causes Charcot-Marie-Tooth Disease in Mice

CMT2Q-causing mutation in the Dhtkd1 gene lead to sensory defects, mitochondrial accumulation and altered metabolism in a knock-in mouse model

A nonsense mutation in DHTKD1 causes Charcot-Marie-Tooth disease type 2 in a large Chinese pedigree.

Aberrant GlyRS-HDAC6 Interaction Linked to Axonal Transport Deficits in Charcot-Marie-Tooth Neuropathy

Mice Carrying an Analogous Heterozygous Dynamin 2 K562E Mutation That Causes Neuropathy in Humans Develop Predominant Characteristics of a Primary Myopathy

Cathepsin D Deficiency Delays Central Nervous System Myelination by Inhibiting Proteolipid Protein Trafficking from Late Endosome/lysosome to Plasma Membrane

Mutations in C1orf194, Encoding a Calcium Regulator, Cause Dominant Charcot-Marie-Tooth Disease

Lack of GDAP1 Induces Neuronal Calcium and Mitochondrial Defects in a Knockout Mouse Model of Charcot-Marie-Tooth Neuropathy

CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase

HADHB Mutations Cause Infantile-Onset Axonal Charcot-Marie-Tooth Disease: A Report of Two Cases

A Novel Missense Mutation in Peripheral Myelin Protein-22 Causes Charcot-Marie-Tooth Disease

Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease

Mfn2R364W, Mfn2G176S, and Mfn2H165R mutations drive Charcot-Marie-Tooth type 2A disease by inducing apoptosis and mitochondrial oxidative phosphorylation damage

Molecular Myelin Dysfunction in the Most Common Inherited Peripheral Neuropathies - CMT1A and HNPP

Similar Clinical, Pathological, and Genetic Features in Chinese Patients with Autosomal Recessive and Dominant Charcot–Marie–Tooth Disease Type 2K

Identification and Functional Characterization of Mutations Within HADHB Associated with Mitochondrial Trifunctional Protein Deficiency.

A new mouse model of Charcot-Marie-Tooth 2J neuropathy replicates human axonopathy and suggest alteration in axo-glia communication

The Hexokinase 1 5′-UTR Mutation in Charcot–Marie–Tooth 4G Disease Alters Hexokinase 1 Binding to Voltage-Dependent Anion Channel-1 and Leads to Dysfunctional Mitochondrial Calcium Buffering

Hydrolytic Cleavage of Optic Atrophy 1 Drives the Pathogenesis of CMT2A Neuropathy Caused by Mfn2 Mutation

Small heat-shock protein 22 mutated in autosomal dominant Charcot-Marie-Tooth disease type 2L

Mutations in MME cause an autosomal‐recessive Charcot–Marie–Tooth disease type 2